(Q37389902)

English

A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant

scientific article published on 22 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

adaptive radiation therapy

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Thomas N Eade

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Eric M Horwitz

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Karen Ruth

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Mark K Buyyounouski

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

David J D'Ambrosio

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Steven J Feigenberg

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

David Y T Chen

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Alan Pollack

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

0 references

publication date

22 January 2008

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

71

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

338-345

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

6 September 2017

Quality of life after treatment for localized prostate cancer: differences based on treatment modality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

14 September 2017

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

28 September 2017

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

28 September 2017

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

28 September 2017

Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Long-term urinary quality of life after permanent prostate brachytherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2763097

2 September 2018

Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose response in prostate cancer with 8-12 years' follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18207665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2007.10.019

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37389902&oldid=2089437512"